232 related articles for article (PubMed ID: 29371688)
1. PD-L1 reverses depigmentation in Pmel-1 vitiligo mice by increasing the abundance of Tregs in the skin.
Miao X; Xu R; Fan B; Chen J; Li X; Mao W; Hua S; Li B
Sci Rep; 2018 Jan; 8(1):1605. PubMed ID: 29371688
[TBL] [Abstract][Full Text] [Related]
2. PD-L1 (Programmed Death Ligand 1) Protects Against Experimental Intracerebral Hemorrhage-Induced Brain Injury.
Han R; Luo J; Shi Y; Yao Y; Hao J
Stroke; 2017 Aug; 48(8):2255-2262. PubMed ID: 28706113
[TBL] [Abstract][Full Text] [Related]
3. Targeting CTLA-4, PD-L1 and IDO to modulate immune responses in vitiligo.
Speeckaert R; van Geel N
Exp Dermatol; 2017 Jul; 26(7):630-634. PubMed ID: 27192950
[TBL] [Abstract][Full Text] [Related]
4. Targeting the PD-1/PD-L1 Axis in Human Vitiligo.
Willemsen M; Melief CJM; Bekkenk MW; Luiten RM
Front Immunol; 2020; 11():579022. PubMed ID: 33240267
[TBL] [Abstract][Full Text] [Related]
5. Replenishing Regulatory T Cells to Halt Depigmentation in Vitiligo.
Le Poole IC; Mehrotra S
J Investig Dermatol Symp Proc; 2017 Oct; 18(2):S38-S45. PubMed ID: 28941492
[TBL] [Abstract][Full Text] [Related]
6. Antigen-specific Helios
Gotot J; Dhana E; Yagita H; Kaiser R; Ludwig-Portugall I; Kurts C
Immunol Cell Biol; 2018 Sep; 96(8):852-862. PubMed ID: 29617057
[TBL] [Abstract][Full Text] [Related]
7. Alteration in regulatory T cells and programmed cell death 1-expressing regulatory T cells in active generalized vitiligo and their clinical correlation.
Tembhre MK; Parihar AS; Sharma VK; Sharma A; Chattopadhyay P; Gupta S
Br J Dermatol; 2015 Apr; 172(4):940-50. PubMed ID: 25376752
[TBL] [Abstract][Full Text] [Related]
8. The co-inhibitory molecule PD-L1 contributes to regulatory T cell-mediated protection in murine crescentic glomerulonephritis.
Neumann K; Ostmann A; Breda PC; Ochel A; Tacke F; Paust HJ; Panzer U; Tiegs G
Sci Rep; 2019 Feb; 9(1):2038. PubMed ID: 30765734
[TBL] [Abstract][Full Text] [Related]
9. Correlation of PD-1/PD-L1 Signaling Pathway with Treg/Th17 Imbalance from Asthmatic Children.
Xi X; Liu JM; Guo JY
Int Arch Allergy Immunol; 2018; 176(3-4):255-267. PubMed ID: 29874664
[TBL] [Abstract][Full Text] [Related]
10. Regulatory T cells in vitiligo: Implications for pathogenesis and therapeutics.
Dwivedi M; Kemp EH; Laddha NC; Mansuri MS; Weetman AP; Begum R
Autoimmun Rev; 2015 Jan; 14(1):49-56. PubMed ID: 25308528
[TBL] [Abstract][Full Text] [Related]
11. Programmed Cell Death Ligand 1-Transfected Mouse Bone Marrow Mesenchymal Stem Cells as Targeted Therapy for Rheumatoid Arthritis.
Hu QY; Yuan Y; Li YC; Yang LY; Zhou XY; Xiong DQ; Zhao ZY
Biomed Res Int; 2021; 2021():5574282. PubMed ID: 34497850
[TBL] [Abstract][Full Text] [Related]
12. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer.
Twyman-Saint Victor C; Rech AJ; Maity A; Rengan R; Pauken KE; Stelekati E; Benci JL; Xu B; Dada H; Odorizzi PM; Herati RS; Mansfield KD; Patsch D; Amaravadi RK; Schuchter LM; Ishwaran H; Mick R; Pryma DA; Xu X; Feldman MD; Gangadhar TC; Hahn SM; Wherry EJ; Vonderheide RH; Minn AJ
Nature; 2015 Apr; 520(7547):373-7. PubMed ID: 25754329
[TBL] [Abstract][Full Text] [Related]
13. CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo.
Eby JM; Kang HK; Tully ST; Bindeman WE; Peiffer DS; Chatterjee S; Mehrotra S; Le Poole IC
J Invest Dermatol; 2015 Jun; 135(6):1574-1580. PubMed ID: 25634358
[TBL] [Abstract][Full Text] [Related]
14. Mutant HSP70 reverses autoimmune depigmentation in vitiligo.
Mosenson JA; Zloza A; Nieland JD; Garrett-Mayer E; Eby JM; Huelsmann EJ; Kumar P; Denman CJ; Lacek AT; Kohlhapp FJ; Alamiri A; Hughes T; Bines SD; Kaufman HL; Overbeck A; Mehrotra S; Hernandez C; Nishimura MI; Guevara-Patino JA; Le Poole IC
Sci Transl Med; 2013 Feb; 5(174):174ra28. PubMed ID: 23447019
[TBL] [Abstract][Full Text] [Related]
15. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high TÂ cells.
Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of PD-L1 and PD-L2 in dermal fibroblasts from alopecia areata mice.
Li Y; Kilani RT; Pakyari M; Leung G; Nabai L; Ghahary A
J Cell Physiol; 2018 Mar; 233(3):2590-2601. PubMed ID: 28777458
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses.
Kitazawa Y; Fujino M; Wang Q; Kimura H; Azuma M; Kubo M; Abe R; Li XK
Transplantation; 2007 Mar; 83(6):774-82. PubMed ID: 17414712
[TBL] [Abstract][Full Text] [Related]
18. HO-1 regulates the function of Treg: Association with the immune intolerance in vitiligo.
Zhang Q; Cui T; Chang Y; Zhang W; Li S; He Y; Li B; Liu L; Wang G; Gao T; Li C; Jian Z
J Cell Mol Med; 2018 Sep; 22(9):4335-4343. PubMed ID: 29974998
[TBL] [Abstract][Full Text] [Related]
19. A quantitative increase in regulatory T cells controls development of vitiligo.
Chatterjee S; Eby JM; Al-Khami AA; Soloshchenko M; Kang HK; Kaur N; Naga OS; Murali A; Nishimura MI; Caroline Le Poole I; Mehrotra S
J Invest Dermatol; 2014 May; 134(5):1285-1294. PubMed ID: 24366614
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T Cells Require CCR6 for Skin Migration and Local Suppression of Vitiligo.
Essien KI; Katz EL; Strassner JP; Harris JE
J Invest Dermatol; 2022 Dec; 142(12):3158-3166.e7. PubMed ID: 35777498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
